Condition
Polycystic Kidney
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Unknown2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05286632Not ApplicableCompleted
KidneYou - Innovative Digital Therapy
NCT03717181UnknownPrimary
Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease
NCT00801268Not ApplicableTerminatedPrimary
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
NCT00491517Phase 2CompletedPrimary
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
NCT00771888Phase 2Unknown
Open-Label Extension of LOCKCYST Trial
Showing all 5 trials